IRIC discoveries have spurred major advances in understanding the development of cancer and opened the way to the creation of new, more targeted therapeutic solutions. Its publications are a reflection of these accomplishments. They also demonstrate the Institute’s drive and productivity.
Cancer: A drug-resistant duo.Nature 2011-12-15;480(7377):329-30.
DNA-binding properties of Smc6, a core component of the Smc5-6 DNA repair complex.Biochem. Biophys. Res. Commun. 2011-12-09;416(1-2):80-5.
PIF1 disruption or NBS1 hypomorphism does not affect chromosome healing or fusion resulting from double-strand breaks near telomeres in murine embryonic stem cells.DNA Repair (Amst.) 2011-11-10;10(11):1164-73.
Wnt4 regulates thymic cellularity through the expansion of thymic epithelial cells and early thymic progenitors.Blood 2011-11-10;118(19):5163-73.
Structural messenger RNA contains cytokeratin polymerization and depolymerization signals.Cell Tissue Res. 2011-11-01;346(2):209-22.
HCaRG accelerates tubular repair after ischemic kidney injury.J. Am. Soc. Nephrol. 2011-11-01;22(11):2077-89.
Incidence and prognostic value of eosinophilia in chronic graft-versus-host disease after nonmyeloablative hematopoietic cell transplantation.Biol. Blood Marrow Transplant. 2011-11-01;17(11):1673-8.
C-terminal domain of MEIS1 converts PKNOX1 (PREP1) into a HOXA9-collaborating oncoprotein.Blood 2011-10-27;118(17):4682-9.